A drug currently used to prevent organ rejection in transplants could also reduce chemotherapy resistance in glioblastoma, according to a Northwestern Medicine study published in Brain. The drug prevents glioblastoma cells from using molecular plasticity to circumvent chemotherapy, and Northwestern…